In addition, ERAP2 knockdown decreased the PSC’s ability to promote migration and the invasion of pancreatic ductal adenocarcinoma (PDAC) by inhibiting ER-derived autophagy, and, in vivo xenografted tumor growth and fibrosis. This evidence concerns the gene ERAP2 and neoplasm.